Search
Mel Snyder
- Nov 9, 2020
- 3 min
Who Lost When an FDA advisory board rejected Biogen’s Alzheimer’s drug aducanumab? (11/9 update)
By Mel Snyder, mel@pro-clinica.com This morning, November 9, 2020, Biogen stock dropped from its $328 close the previous Friday to $230...
19 views0 comments
Mel Snyder
- Oct 13, 2020
- 1 min
Mask vs. Vaccine? CDC's Redfield says "both"
A month ago, CDC head Robert Redfield startled a Senate committee when he emphatically stated that “this face mask is more guaranteed to...
8 views0 comments